Animalcare Group Plc

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB0032350695
GBP
2.85
-0.12 (-4.04%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard

1

Poor Management Efficiency with a low ROE of 2.77%

  • The company has been able to generate a Return on Equity (avg) of 2.77% signifying low profitability per unit of shareholders funds
2

Low Debt Company with Strong Long Term Fundamental Strength

 
3

The company declared negative results in Dec'24 after positive results in Jun'24

4

With ROE of 3.93%, it has a expensive valuation with a 1.32 Price to Book Value

5

Market Beating performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

GBP 182 Million (Small Cap)

stock-summary
P/E

34.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.98%

stock-summary
Debt Equity

0.08

stock-summary
Return on Equity

3.93%

stock-summary
Price to Book

1.60

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
27.23%
0%
27.23%
6 Months
16.33%
0%
16.33%
1 Year
15.85%
0%
15.85%
2 Years
57.02%
0%
57.02%
3 Years
-3.72%
0%
-3.72%
4 Years
-21.27%
0%
-21.27%
5 Years
70.15%
0%
70.15%

Animalcare Group Plc for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
3.12%
EBIT Growth (5y)
12.41%
EBIT to Interest (avg)
2.47
Debt to EBITDA (avg)
0.50
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
0.74
Tax Ratio
16.79%
Dividend Payout Ratio
64.02%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.86%
ROE (avg)
2.77%

Valuation key factors

Factor
Value
P/E Ratio
34
Industry P/E
Price to Book Value
1.32
EV to EBIT
26.63
EV to EBITDA
11.21
EV to Capital Employed
1.29
EV to Sales
1.95
PEG Ratio
NA
Dividend Yield
82.05%
ROCE (Latest)
4.85%
ROE (Latest)
3.93%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Animalcare Group Plc"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 3.91% vs -3.24% in Dec 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -40.00% vs 2,100.00% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "74.40",
          "val2": "71.60",
          "chgp": "3.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12.50",
          "val2": "12.90",
          "chgp": "-3.10%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.90",
          "val2": "0.60",
          "chgp": "50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.10",
          "val2": "-1.70",
          "chgp": "105.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.20",
          "val2": "2.00",
          "chgp": "-40.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "64.80%",
          "val2": "70.80%",
          "chgp": "-0.60%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Annual Results Snapshot (Consolidated) - Dec'23stock-summary

Dec'23
Dec'22
Change(%)
Net Sales
74.40
71.60
3.91%
Operating Profit (PBDIT) excl Other Income
12.50
12.90
-3.10%
Interest
0.90
0.60
50.00%
Exceptional Items
0.10
-1.70
105.88%
Consolidate Net Profit
1.20
2.00
-40.00%
Operating Profit Margin (Excl OI)
64.80%
70.80%
-0.60%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is 3.91% vs -3.24% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -40.00% vs 2,100.00% in Dec 2022

stock-summaryCompany CV
About Animalcare Group Plc stock-summary
stock-summary
Animalcare Group Plc
Pharmaceuticals & Biotechnology
Animalcare Group plc is a United Kingdom-based sales, marketing and product development company. The Company is principally engaged in the development, sale and distribution of licensed veterinary pharmaceuticals and identification products and services to companion animal veterinary markets. The Company develops and sells goods and services to veterinary professionals principally for use in companion animals, operating through the United Kingdom wholesalers and distribution and development partners in markets in Western Europe. The Company's product portfolio is divided into three product groups: pharmaceuticals (Licensed Veterinary Medicines); pet microchips (Companion Animal Identification), and consumable items (Animal Welfare Products). Animalcare Ltd is the Company's subsidiary. It has operations in the United Kingdom, Europe and Rest of World.
Company Coordinates stock-summary
Company Details
7 Unit York Business Park, 10 Great North Way YORK None : YO26 6RB
Registrar Details